Professor
Tae-In Kam
- Alzheimer’s disease
- Parkinson’s disease
- Neurodegenerative disease
- Neurons
- Glia
- Neuroinflammation
- Drug development
-
Education
Ph.D. in Biological Sciences, Seoul National University (2013)
-
Location
W13, 505
- Phone
-
Laboratory
BRain and Integrated Neurodegenerative Diseases (BRaIN) Lab
Biosketch
- Dr. Tae-In Kam is a neuroscientist who studies the causes and treatment methods of neurodegenerative diseases. He is an assistant professor in the Department of Brain and Cognitive Sciences at KAIST.
- Dr. Kam completed his bachelor's degree at the Department of Biological Sciences at Seoul National University, and received his doctorate from the same university for Alzheimer's disease research. He conducted research on Parkinson's disease as a postdoctoral researcher at the Johns Hopkins University School of Medicine. Since 2019, he has worked as an assistant professor in the Department of Neurology at Johns Hopkins University School of Medicine.
- Dr. Kam has published more than 40 papers in prominent scientific journals such as Science, Cell, Nature Medicine, Science Translational Medicine, and PNAS. He conducted research covering various neurodegenerative diseases by receiving R01 research funds from the NIA and NINDS of the US National Institutes of Health (NIH) and research funds from various brain disease-related Foundations. He was also awarded many Excellences in Research Awards.
- The BRain and Integrated Neurodegenerative Diseases (BRaIN) Lab / Kam Lab focuses on the neuronal and non-neuronal mechanisms of the pathogenesis of neurological disorders. We attempt to understand events in the brains of those with neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease using a variety of research techniques, including high-throughput screening, human stem cell studies, and preclinical animal models. The overarching goal of the research is to understand death and survival mechanisms in order to identify novel targets that are essential for the pathogenesis of neurodegenerative diseases and for developing disease-modifying therapies.
Key Papers
- Chun YS, Kim MY, Lee SY, Kim MJ, Hong TJ, Jeon JK, Ganbat D, Kim HT, Kim SS, Kam T.-I#, Han S#. (2022) MEK1/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal
Courses
- Neurons and Glia
- Aging and Neurodegenerative Disorders